XLIFE SCIENCES AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.4 CHF | -3.28% |
|
+0.28% | -29.06% |
| Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XLIFE SCIENCES AG | Other Biotechnology & Medical Research | -3.28% | +0.28% | -29.06% | +1.14% | - | 224M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- XLS Stock
- Charts Xlife Sciences AG
- Comparison Chart
